Vor Biopharma, Inc. (VOR)

NASDAQ: VOR · IEX Real-Time Price · USD
8.19 -0.21 (-2.50%)
Jan 24, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202020192018
Selling, General & Admin
11.754.220.43
Research & Development
31.626.22.43
Operating Expenses
43.3710.422.86
Operating Income
-43.37-10.42-2.86
Interest Expense / Income
00.611
Other Expense / Income
-0.03-0.190.29
Pretax Income
-43.34-10.84-4.15
Net Income
-43.34-10.84-4.15
Preferred Dividends
5.931.770
Net Income Common
-49.26-12.61-4.15
Shares Outstanding (Basic)
21411588
Shares Outstanding (Diluted)
21411588
Shares Change
85.85%30.97%-
EPS (Basic)
-230.57-109.70-47.30
EPS (Diluted)
-230.57-109.70-47.30
Free Cash Flow Per Share
-0.19-0.09-0.03
EBITDA
-41.95-10.14-3.13
EBIT
-43.34-10.23-3.15
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).